24
Participants
Start Date
December 18, 2019
Primary Completion Date
September 1, 2024
Study Completion Date
September 1, 2024
Spironolactone
Spironolactone is an androgen-receptor commonly used (off-label) for hyperandrogenism in girls and women. It is used in this study to determine if androgen blockade can improve ovulation rates in girls with androgen excess, who often have low rates of ovulation in the years following menarche. The spironolactone dose will be as follows: If ≤ 60 kg, 50 mg twice daily; if \> 60 kg, 100 mg twice daily.
RECRUITING
University of Virginia Center for Research in Reproduction, Charlottesville
The Waterloo Foundation
OTHER
University of Virginia
OTHER